APLS Apellis Pharmaceuticals Inc
APLS Stock Analysis Overview
What this means: InvestorsObserver gives Apellis Pharmaceuticals Inc (APLS) an overall rank of 34, which is below average. Apellis Pharmaceuticals Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of stocks appear more favorable to our system.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
APLS Fundamental Analysis
Upgrade to Premium to unlock Fundamental Ranking
APLS Short-Term Technical Analysis
Upgrade to Premium to unlock Short-Term Technical Ranking
APLS Long-Term Technical Analysis
Upgrade to Premium to unlock Long-Term Technical Ranking
APLS Analyst Ranking
Upgrade to Premium to unlock Analyst Ranking Analysis
APLS Valuation Ranking Analysis
Upgrade to Premium to unlock Valuation Ranking
APLS Stock Sentiment Analysis
Upgrade to Premium to unlock Stock Sentiment Ranking
APLS Stock Analysis Overview
What this means: InvestorsObserver gives Apellis Pharmaceuticals Inc (APLS) an overall rank of 34, which is below average. Apellis Pharmaceuticals Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of stocks appear more favorable to our system.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.